Hongfei Wu Selected Research

paeonol

2/2024	MicroRNA let-7g links foam cell formation and adipogenic differentiation: A key regulator of Paeonol treating atherosclerosis-osteoporosis.
1/2024	Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway.
10/2023	Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice.
1/2023	Paeonol Attenuates the Endothelial-to-Mesenchymal Transition Induced by TGF-β1 in Human Umbilical Vein Endothelial Cells through ALK5- Smad2/3 Signaling Pathway.
1/2022	Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: A novel mechanism for paeonol in atherosclerosis treatment.
1/2021	Paeonol Attenuated Vascular Fibrosis Through Regulating Treg/Th17 Balance in a Gut Microbiota-Dependent Manner.
10/2020	Paeonol inhibits NLRP3 mediated inflammation in rat endothelial cells by elevating hyperlipidemic rats plasma exosomal miRNA-223.
1/2018	Paeonol Attenuated Inflammatory Response of Endothelial Cells via Stimulating Monocytes-Derived Exosomal MicroRNA-223.
1/2018	Paeonol Inhibits Oxidized Low-Density Lipoprotein-Induced Vascular Endothelial Cells Autophagy by Upregulating the Expression of miRNA-30a.
1/2017	The Anti-atherosclerotic Effect of Paeonol against Vascular Smooth Muscle Cell Proliferation by Up-regulation of Autophagy via the AMPK/mTOR Signaling Pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongfei Wu Research Topics

Disease

15	Atherosclerosis 04/2024 - 01/2017
7	Hepatolenticular Degeneration (Wilson's Disease) 05/2023 - 02/2019
6	Inflammation (Inflammations) 01/2024 - 01/2018
6	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 08/2004
5	Neoplasms (Cancer) 04/2023 - 01/2012
3	Osteosarcoma (Osteogenic Sarcoma) 04/2023 - 10/2019
3	Hypersplenism (Anemia, Splenic) 10/2021 - 10/2016
3	Infections 08/2020 - 08/2019
2	Iron Overload 05/2023 - 01/2022
2	Dysbiosis 08/2022 - 01/2022
2	Necrosis 12/2021 - 08/2020
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 04/2024
1	Osteoporosis 02/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Vascular Calcification 11/2023
1	Sarcoma (Soft Tissue Sarcoma) 11/2023
1	Osteoarthritis 10/2023
1	Hypoxia (Hypoxemia) 04/2023
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Pure Red-Cell Aplasia 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Large Granular Lymphocytic Leukemia 01/2022
1	Alcoholic Fatty Liver 12/2021
1	Portal Hypertension 10/2021
1	Aortic Dissection 09/2021
1	Acute Lung Injury 09/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Osteomyelitis 08/2020
1	Diabetic Foot 08/2020
1	Foot Ulcer 08/2020
1	Ulcer 08/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2019
1	Hypokalemia 12/2019
1	Acidosis 12/2019
1	Chronic Hepatitis B 11/2019
1	Congenital Abnormalities (Deformity) 08/2019
1	Secondary Hyperparathyroidism 01/2019
1	Hoarseness 01/2019
1	Obstructive Jaundice (Cholestatic Jaundice) 06/2018

Drug/Important Bio-Agent (IBA)

11	paeonolIBA 02/2024 - 01/2015
7	Apolipoproteins E (ApoE)IBA 03/2024 - 01/2017
5	gualou xiebai baijiutangIBA 04/2024 - 01/2022
5	CopperIBA 05/2023 - 02/2019
4	LipidsIBA 02/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 04/2023 - 04/2011
2	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2019
2	Sirtuin 1IBA 01/2024 - 11/2023
2	AcidsIBA 10/2023 - 01/2022
2	CurcuminIBA 05/2023 - 12/2021
2	Circular RNAIBA 04/2023 - 10/2019
2	CateninsIBA 04/2020 - 10/2019
2	Docetaxel (Taxotere)FDA Link 01/2013 - 04/2011
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 05/2008 - 10/2004
1	CholesterolIBA 04/2024
1	oxidized low density lipoproteinIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2023
1	Drinking WaterIBA 10/2023
1	EnzymesIBA 10/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2023
1	Heavy MetalsIBA 08/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2022
1	lipopolysaccharide AIBA 01/2022
1	14,15-dihydroxyeicosatrienoic acidIBA 01/2022
1	metal transporting protein 1 (ferroportin)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	OsteopontinIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2021
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Oxygen (Dioxygen)IBA 09/2021
1	Receptor for Advanced Glycation End ProductsIBA 09/2021
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	CollagenIBA 01/2021
1	InflammasomesIBA 10/2020
1	ChromatinIBA 01/2020
1	ElectrolytesIBA 12/2019
1	baicalinIBA 11/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2019
1	Phosphorus (Red Phosphorus)IBA 01/2019
1	Parathyroid Hormone (Parathormone)IBA 01/2019
1	CalciumIBA 01/2019

Therapy/Procedure

3	Splenectomy 10/2021 - 10/2016
2	Therapeutics 04/2023 - 01/2022
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2020 - 01/2020
1	Fecal Microbiota Transplantation 01/2022
1	Bone Lengthening 08/2020
1	Surgical Amputation (Amputations) 08/2020
1	Debridement 08/2020
1	Cystectomy 12/2019
1	Osteotomy 08/2019
1	Renal Dialysis (Hemodialysis) 01/2019
1	Parathyroidectomy 01/2019
1	Ligation 06/2018